Eithan Galun
12Patents
4h-index
34Co-inventors
60Inventor score
Filing activity: Apr 23, 1993 → May 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8435791B2 | Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage | Human Necessities | 24 | Expired |
| US5610050A | Methods of preventing viral replication | Chemistry; Metallurgy | 19 | Expired |
| US6410009B1 | Pharmaceutical composition for treating hepatitis B virus (HBV) infection | Human Necessities | 6 | Expired |
| US5919763A | IL-6/SIL-6R complex for promotion of liver functions | Human Necessities | 5 | Expired |
| US6368602B1 | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine | Chemistry; Metallurgy | 4 | Expired |
| US7615209B2 | Compositions of NDV and methods of use thereof for treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US8372389B2 | Methods for the treatment of radiation or chemotherapy-induced tissue damage | Chemistry; Metallurgy | 0 | Active |
| US7897145B2 | Methods for the treatment of renal failure | Human Necessities | 0 | Active |
| US6217858A | Pharmaceutical composition for treating hepatitis B virus (HBV) infection | Human Necessities | 0 | Expired |
| US10392617B2 | miR-122* as an active micro-RNA, compositions comprising the same and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11865090B2 | Tumor suppressive microRNAs for cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US12318393B2 | Modulators of orphan nuclear receptors for NASH and other metabolic disorders | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.